Linked Life Data

11387359

Source:http://linkedlifedata.com/resource/pubmed/id/11387359

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2001-6-1
pubmed:abstractText
This randomized, double-blind, placebo-controlled clinical trial assessed the effects of epoetin alfa on transfusion requirements, hematopoietic parameters, quality of life (QOL), and safety in anemic cancer patients receiving nonplatinum chemotherapy. The study also explored a possible relationship between increased hemoglobin and survival.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2865-74
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:11387359-Activities of Daily Living, pubmed-meshheading:11387359-Adolescent, pubmed-meshheading:11387359-Adult, pubmed-meshheading:11387359-Aged, pubmed-meshheading:11387359-Aged, 80 and over, pubmed-meshheading:11387359-Anemia, pubmed-meshheading:11387359-Antineoplastic Agents, pubmed-meshheading:11387359-Blood Transfusion, pubmed-meshheading:11387359-Double-Blind Method, pubmed-meshheading:11387359-Erythropoietin, pubmed-meshheading:11387359-Fatigue, pubmed-meshheading:11387359-Female, pubmed-meshheading:11387359-Hematinics, pubmed-meshheading:11387359-Hemoglobins, pubmed-meshheading:11387359-Humans, pubmed-meshheading:11387359-Male, pubmed-meshheading:11387359-Middle Aged, pubmed-meshheading:11387359-Neoplasms, pubmed-meshheading:11387359-Placebos, pubmed-meshheading:11387359-Quality of Life, pubmed-meshheading:11387359-Recombinant Proteins, pubmed-meshheading:11387359-Survival Analysis, pubmed-meshheading:11387359-Treatment Outcome
pubmed:year
2001
pubmed:articleTitle
Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.
pubmed:affiliation
John Radcliffe Hospital, Oxford, United Kingdom. tim.littlewood@orh.anglox.nhs.uk
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study